Skip to main content
TipRanks
Go Ultimate75% OFF

Shattuck Labs (STTK) Drug Pipeline

280 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Sl-325Hidradenitis Suppurativa (Hs)Phase IINot Yet RecruitingA Study of SL-325 in Participants With Hidradenitis SuppurativaNov 06, 2026―
Sl-325Crohn's DiseasePhase IIRecruitingA Study of SL-325 in Crohn's Disease PatientsAug 04, 2026
Sl-325Healthy VolunteersPhase IActive Not RecruitingPhase 1 Study of SL-325 in Healthy VolunteersAug 28, 2025
Pegylated Liposomal Doxorubicin + Sl-172154, Mirvetuximab + Sl-172154Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma, Ovarian Cancer, Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Primary Peritoneal Carcinoma, Platinum-Resistant Ovarian CancerPhase ICompletedPhase 1b Study of SL-172154 Administered with Combination Agent(s) in Subjects with Ovarian CancersJul 26, 2022―
Venetoclax, Sl-172154, AzacitidineAcute Myeloid Leukemia, Myelodysplastic SyndromesPhase ICompletedPhase 1 Study of Shattuck Labs (SL)-172154 in Subjects With MDS or AMLFeb 15, 2022―
Drug: Sl-172154Cutaneous Squamous Cell Carcinoma, Squamous Cell Carcinoma Of Head And NeckPhase ITerminatedPh1 Study of SL-172154 Administered Intratumorally in Subjects With Squamous Cell Carcinoma of the Head and Neck or SkinJul 31, 2020―
Sl-172154Fallopian Tube Cancer, Primary Peritoneal Carcinoma, Ovarian CancerPhase ICompletedPhase 1 Study of SL-172154 (SIRPα-Fc-CD40L) in Subjects With Ovarian CancerMay 19, 2020―
Sl-279252Melanoma, Urothelial Carcinoma, Non Small Cell Lung Cancer, Renal Cell Carcinoma, Diffuse Large B Cell Lymphoma, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Hodgkin Lymphoma, Squamous Cell Carcinoma Of The Head And Neck, Squamous Cell Carcinoma Of The Anus, Squamous Cell Carcinoma Of The Cervix, Squamous Cell Carcinoma Of The Skin, Mismatch Repair Deficient Or Msi-High Solid TumorsPhase ICompletedSL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or LymphomasJan 10, 2019―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Shattuck Labs, Inc. (STTK) have in its pipeline
Shattuck Labs STTK is currently developing the following drugs: Sl-325, Pegylated Liposomal Doxorubicin + Sl-172154, Mirvetuximab + Sl-172154, Venetoclax, Sl-172154, Azacitidine, Drug: Sl-172154, Sl-172154, Sl-279252. These drug candidates are in various stages of clinical development as the company works toward FDA approval.